RxDoctor Payments Data

Dustin Meyers, MD

Family Medicine · Sutherlin, ORNPI 1427587948

Payments from drug & device makers

$227in general payments, 2019–2025

Across 12 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$60
  • Tandem Diabetes Care, Inc.$40
  • Radius Health, Inc.$28
  • E.r. Squibb & Sons, L.L.C.$24
  • Pfizer$21
  • Novartis$19
  • plus $36 from 3 others

What the payments were for

  • Food & beverage$227100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$227 in reported general payments places this provider in the 65th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$3,366
Medicare patients
62
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban125$137,975
JardianceEmpagliflozin103$105,469
OzempicSemaglutide70$99,863
XareltoRivaroxaban73$94,550
FarxigaDapagliflozin Propanediol62$46,536
TrulicityDulaglutide32$30,385
Tresiba Flextouch U-200Insulin Degludec24$20,718
RybelsusSemaglutide13$20,101
Semglee (Yfgn) PenInsulin Glargine-Yfgn28$19,697
Tresiba Flextouch U-100Insulin Degludec23$17,772
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$14,575
MounjaroTirzepatide14$14,511
JanuviaSitagliptin Phosphate15$13,626
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$10,105
Spiriva RespimatTiotropium Bromide11$8,453

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$137,975125 claims
Novo NordiskOzempic, Rybelsus$60$119,96483 claims
GSKTrelegy Ellipta, Shingrix$13$14,88333 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Sutherlin

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →